BMY Oct 2024 52.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:11PM EDT. Market open.
| Previous close | 0.6000 |
| Open | 0.5100 |
| Bid | 0.3500 |
| Ask | 0.3800 |
| Strike | 52.50 |
| Expiry date | 2024-10-18 |
| Day's range | 0.3900 - 0.5200 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.16k |
ZacksBristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
The latest trading day saw Bristol Myers Squibb (BMY) settling at $54.20, representing a +0.82% change from its previous close.
Business WireU.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
PRINCETON, N.J., October 03, 2024--U.S. FDA Approves Perioperative Treatment of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo...
Investor's Business DailyBristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
© 2024 Yahoo. All rights reserved.